Structure and contribution to the heparin cofactor II-mediated inhibition of thrombin of naturally oversulphated sequences of dermatan sulphate
- 15 December 1993
- journal article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 296 (3) , 639-648
- https://doi.org/10.1042/bj2960639
Abstract
Dermatan sulphate (DS) obtained from bovine and pig mucosa and pig skin, and charge-enriched fractions of a selected DS preparation, were characterized in terms of charge density, M(r) and disaccharide composition of chondroitin ABC lyase digests, and by 13C-n.m.r. spectroscopy. Besides the major IdoA-GalNAc4SO3 sequences, all DS preparations contain about 10% disulphated disaccharide sequences (mostly IdoA2SO3-GalNAc4SO3, with minor amounts of IdoA-GalNAc4,6SO3). DS fragments (prepared by radical-catalysed depolymerization of DS and retaining the internal structure of the parent polysaccharide) as well as Smith degraded fragments [SD-DS, obtained by controlled degradation of periodate-oxidized and borohydride-reduced DS (RO-DS)] with the general structure GalNAc4SO3(IdoA2SO3-GalNAc4SO3)n-R (where R is the remnant of a glycol-split uronic acid, and n = 2-3 and 3-4) were characterized by one- and two-dimensional 1H-n.m.r., 13C-n.m.r. and disaccharide composition analysis. In accordance with previous findings [Maimone and Tollefsen (1990) J. Biol. Chem. 265, 18263-18271], only fragments with n > or = 3 significantly enhance the heparin cofactor II-mediated inhibition of thrombin. In natural DS preparations and their fractions, this activity (as well as the antithrombotic activity in an animal model) appears to require IdoA2SO3-containing sequences. The heparin cofactor II activity of DS, RO-DS and SD-DS fragments decreases with decreasing M(r). However, RO-DS fragments are more active than DS fragments of similar M(r), probably because of the extra flexibility endowed by glycol-split IdoA residues.Keywords
This publication has 28 references indexed in Scilit:
- Physicochemical Aspects of Heparin Cofactor IIaAnnals of the New York Academy of Sciences, 1989
- Effects of Dermatan Sulfate and Heparin on Inhibition of Thrombus Growth in VivoAnnals of the New York Academy of Sciences, 1989
- Plasma Anticoagulant Mechanisms of Heparin, Heparan Sulfate, and Dermatan SulfateaAnnals of the New York Academy of Sciences, 1989
- Studies on the structural requirements of heparin for the catalysis of thrombin inhibition by heparin cofactor IIBiochimica et Biophysica Acta (BBA) - General Subjects, 1988
- Conformational flexibility: a new concept for explaining binding and biological properties of iduronic acid-containing glycosaminoglycansTrends in Biochemical Sciences, 1988
- Isolation of dermatan sulfate with high heparin cofactor II-mediated thrombin-inhibitory activity from porcine spleenBiochimica et Biophysica Acta (BBA) - General Subjects, 1987
- Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharidesBritish Journal of Haematology, 1986
- Assay of dermatan sulfate cofactor (heparin cofactor II) activity in human plasmaThrombosis Research, 1984
- Failure of aspirin at different doses to modify experimental thrombosis in ratsThrombosis Research, 1980
- Glycosaminoglycans and Their Binding to Biological MacromoleculesAnnual Review of Biochemistry, 1978